SpacePharma
{{Short description|Microgravity research and manufacturing company}}
{{Use American English|date=June 2023}}
{{Use dmy dates|date=June 2023}}
{{Infobox company
| name = SpacePharma
| logo = SpacePharma Logo.png
| logo_size =
| image =
| type = Privately held company
| traded_as =
| founded = 2012
| founder = Yossi Yamin, Martin Aebi (Ido Priel left his active position)
| hq_location_city = Courgenay
| hq_location_country = Switzerland
| industry = Space industry, biotechnology
| services = Microgravity research
| products = SPMG, NEXUS, DIDO, SPAd, SPID, MOTI
| revenue =
| revenue_year =
| num_employees = apx 20
| num_employees_year =
| website = {{URL|https://www.spacepharma.health/|spacepharma.health}}
| footnotes =
}}
SpacePharma is a Swiss–Israeli biotechnology company with a primary focus on conducting scientific experiments in microgravity conditions. The company was the first fully private, commercially oriented company established with the specific intention to conduct pharmaceutical research and development (R&D) and manufacturing in space.{{cite news |title=SpacePharma CEO Yossi Yamin Leads The Company To New Heights |url=https://www.sciencetimes.com/articles/38910/20220721/spacepharma-ceo-yossi-yamin-leads-the-company-to-new-heights.htm |publisher=The Science Times |date=July 21, 2022}}
The company was founded by Yossi Yamin, a former Commander of an Israeli Satellite Unit in the Israeli Defense Forces (IDF). As of the mid-2020s, SpacePharma has offices in Herzliya, Israel; Courgenay, Switzerland; and Palo Alto, California, with a Space Life Sciences Lab in Exploration Park, Florida, US.{{cite news |title=SpacePharma SA launches American subsidiary, SpacePharma, Inc. |url=https://spaceref.com/press-release/spacepharma-sa-launches-american-subsidiary-spacepharma-inc/ |publisher=SpaceREF |date=August 16, 2016}}
Overview
The company operates miniaturized, unmanned, remotely controlled, and fully automated labs based on lab-on-a-chip (LOC) technology, which are suitable for a wide variety of life science and chemistry experiments. These labs are designed to conduct research in space and to leverage the microgravity conditions that can't be replicated in terrestrial settings.{{cite news |title=Israeli experiments in space: The future is here! |url=https://www.jpost.com/science/article-705829 |agency=Jerusalem Post |date=May 9, 2022}}
Operations
SpacePharma's operations include the launch and operation of free-orbit satellites and labs onboard the International Space Station (ISS).
The company's DIDO-2 and DIDO-3 satellites were launched in 2017 and 2020 respectively, carrying experiments to study crystallization, emulsion, enzyme activity and antimicrobial resistance in microgravity.{{cite news |title=מעבדה רפואית בחלל: מחר ישוגר הלוויין הראשון של חברת SpacePharma |url=https://www.hayadan.org.il/spacepharma-lounch-1402172 |agency=Hayadan |date=February 14, 2017}}{{cite news |title=Israel makes history, launches DIDO III satellite into space |url=https://www.jpost.com/health-science/israel-makes-history-launchs-dido-iii-satellite-into-space-640918 |access-date=September 3, 2020 |agency=Jerusalem Post}}
Additionally, SpacePharma has launched at least 7 autonomous labs to the ISS since 2017, starting with the NEXUS-1{{cite web |url=https://www.israelandstuff.com/israels-mini-space-lab-arrives-at-international-space-station |website=IsraelandStuff.com |access-date=November 15, 2017 | title=Israel's mini space lab arrives at International Space Station |date=15 November 2017 }} and NEXUS-2 labs,{{cite news |title=מעבדת חלל של ספייס פארמה המכילה ניסוי בתאי גזע תשוגר מחר (שבת) לתחנת החלל הבין-לאומית |url=https://www.hayadan.org.il/space-pharma-lab-to-lounch-friday-1611187 |publisher=hayadan |date=November 16, 2018}} followed by the SPAd and SPAd-2 labs.{{cite web |title=SpacePharma launched to the ISS aboard all-private Axiom-1 Mission |url=https://bsgn.esa.int/2022/04/07/spacepharma-launching-to-iss-on-axiom-1/ |website=ESA BSGN|date=7 April 2022 }}{{cite news |title=Cutiss has skin in the space game with new study on the International Space Station |url=https://tech.eu/2023/03/18/cutiss-has-skin-in-the-space-game-with-new-study-on-the-international-space-station/ |publisher=Tech EU |date=March 18, 2023}} In April 2022 a SPAd-2 lab was delivered to the ISS on the Axiom-1 mission, where it performed a series of experiments studying bone loss, DNA damage repair, and the cultivation of cultured meat in space.
SpacePharma has announced it is working on a large scale pharmaceutical manufacturing facility in orbit named MoTi.{{cite news |title=Israel's SpacePharma is pioneering the 'Made in Space' revolution |url=https://www.calcalistech.com/ctech/articles/0,7340,L-3893233,00.html |publisher=Calcalist Tech |date=February 12, 2021}}